Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
株式のランク #18713
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
株価
$2.49
時価総額
$4.47M
変化(1日)
-4.01%
変化(1年)
678.16%
MY
取引 BioNexus Gene Lab Corporation (BGLC)

カテゴリー

BioNexus Gene Lab Corporation(BGLC)の株式分割履歴
BioNexus Gene Lab Corporation株(シンボル:BGLC)は合計で2回の株式分割を実施しました。
最新の株式分割はApr 07, 2025に行われました。
Jul 20, 2023より前に購入されたBGLC株は、現在0.0083333333333333BGLC株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
2025-04-07 1:10 x0.1 x0.0083333333333333
2023-07-20 1:12 x0.083333333333333 x0.083333333333333
類似企業または競合他社の株式分割